baber/WOPTO huggingface dataset:
Patent AU-2850000-A (AU)
Title: Heat and moisture exchanger comprising hydrophilic nylon and methods of using same
Inventor: BERGER RICHARD M
IPC: D04H1/42
Filed: 2000-01-18
Abstract: A heat and moisture exchanger including a gas-permeable element, preferably a fibrous media, adapted to be warmed and to trap moisture from a patient's breath during exhalation and to be cooled and to release the trapped moisture for return to the patient during inspiration to effectively conserve the humidity and body heat of the patient's respiratory tract, wherein the media comprises a hydrophilic nylon polymer. The gas-permeable element can be formed entirely of monocomponent fibers of the hydrophilic nylon polymer or, preferably, fibers comprising at least a sheath of the hydrophilic nylon polymer can be bonded at their points of contact by a bonding agent, such as a polyester. Bicomponent fibers comprising a sheath of the hydrophilic nylon polymer can be bonded by other bicomponent fibers comprising a sheath of the bonding agent, with all of the bicomponent fibers comprising a core of a thermoplastic polymer, such as polypropylene, to minimize the cost and increase the strength of the heat and moisture exchanger element.
Patent AU-3070695-A (AU)
Title: Compounds for and method of inhibiting phosphodiesterase iv
Inventor: CAVALLA DAVID
IPC: A61K31/433
Filed: 1995-06-23
Abstract: Novel compounds which are effective PDE IV inhibitors are disclosed. The compounds possess similar or improved PDE IV inhibition as compared to rolipram, with improved selectivity with regard to, e.g., PDE III inhibition. Preferred compounds are 3-(3-cyclopentyloxy-4-methoxy-benzylamino)-4-hydroxymethyl pyrazole and 3-(3-cyclopentyloxy-4-methoxybenzylamino)-4-methoxymethylpyrazole.
Patent AU-3109595-A (AU)
Title: Novel process for the production of biologically active dimeric protein
Inventor: CERLETTI NICO
IPC: C07K14/495
Filed: 1995-07-12
Abstract: The present invention relates to a folding process for the preparation of biologically active, dimeric TGF- beta  (Tranforming Growth Factor type  beta )-like protein.
Patent AU-3141393-A (AU)
Title: Gram-negative bacterial vaccines
IPC: A61K39/102
Filed: 1992-11-13
Abstract: PCT No. PCT/US92/09944 Sec. 371 Date Jul. 11, 1994 Sec. 102(e) Date Jul. 11, 1994 PCT Filed Nov. 13, 1992 PCT Pub. No. WO93/10216 PCT Pub. Date May 27, 1993There is provided by this invention a novel method of preparing Gram-negative bacterial vaccines. The method comprises providing a concentrated Gram-negative bacterial antigenic preparation,adsorbing the preparation with a mineral carrier capable of binding free-endotoxin in the antigenic preparation in an amount effective to produce optimal binding of endotoxin and antigen and diluting the adsorbed preparation for use in a vaccine. Also provided by this invention is a vaccine produced by the method of this invention. Also provided by this invention is a Gram-negative bacterial vaccine wherein the improvement comprises a concentration of mineral carrier in the vaccine which is less than 5.0% v/v. Also provided by this invention is a Gram-negative bacterial vaccine comprising a mineral carrier wherein the amount of the mineral carrier in the vaccine has been predetermined by the method of this invention. Also provided by this invention is a method of vaccinating an animal against Gram-negative bacterial infections comprising administering to the animal an effective amount of a vaccine of this invention.
Patent AU-3217693-A (AU)
Title: Aminobenzoic acid derivatives
IPC: C07D451/04
Filed: 1993-02-03
Abstract: An aminobenzoic acid derivative represented by the following general formulas (I), (I-2) or (I-3), or a pharmacologically acceptable salt thereof, which exhibits a serotonin antagonism and an acetylcholine release accelerating activity at a well-balanced activity ratio and which is efficacious as a drug for patients with gastrointestinal unindentified complaints: <CHEM>  and <CHEM> wherein R<1> represents a group such as an alkynyl or cyanoalkyl group; R<2> represents a group such as an amino or acylamino group; R<3> represents a halogen atom; X represents -O- or -NH-; and A represents an oxygen or sulfur atom.
Patent AU-3272601-A (AU)
Title: Method of inhibiting soil redeposition
Inventor: SLIVA PHILIP G
IPC: C11D3/37
Filed: 2000-11-29
Abstract: A method of inhibiting soil redeposition on fabric stained by one or more quaternary compounds by providing a sulfonated material in an effective amount to a wash liquor. The sulfonated material includes water-soluble sulfonated polymers. Generally, the sulfonated material is incorporated with a laundry detergent to provide a use level of about 30 ppm to about 300 ppm in the wash liquor.
Patent AU-3322095-A (AU)
Title: Multiple access coding using bent sequences for mobile radio communications
Inventor: BOTTOMLEY GREGORY E
IPC: H04B1/707
Filed: 1995-08-11
Abstract: Information symbols spread using orthogonal or bi-orthogonal codewords are assigned a unique scramble mask that is taken from a set of scramble masks having selected correlation properties. The set of scramble masks is selected such that the correlation between the modulo-2 sum of two scramble masks with any codeword is a constant magnitude, independent of the codeword and the individual masks being compared. In one embodiment, when any two masks are summed using modulo-2 arithmetic, the Walsh transformation of that sum results in a maximally flat Walsh spectrum. For cellular radio telephone systems using subtractive CDMA demodulation techniques, a two-tier ciphering system ensures security at the cellular system level by using a pseudorandomly generated code key to select one of the scramble masks common to all of the mobile stations in a particular cell. Also, privacy at the individual mobile subscriber level is ensured by using a pseudorandomly generated ciphering key to encipher individual information signals before the scrambling operation.
Patent AU-3369584-A (AU)
Title: Tetra hydro thiopyran -3-yl - cyclohexenone derivatives
Inventor: BECKER RAINER
IPC: C07D/
Filed: 1984-09-28
Abstract: Cyclohexenone derivatives of the formula   <IMAGE>   where R1 is alkyl and R2 is chloroalkenyl are useful in controlling undesirable plant growth.
Patent AU-3402489-A (AU)
Title: A method of packaging a beverage
Inventor: BYRNE WILLIAM JOHN
IPC: B65B3/04
Filed: 1989-05-04
Abstract: A method of packaging a beverage having gas in solution therewith in which an open topped container (1) is charged with the beverage through the open top. The container is purged of air and pressurised with a gas selected from carbon dioxide, nitrogen or other inert gas and a partition wall (5) having a restricted orifice (9) is located over the beverage and sealed to the container (1) to form a primary chamber (10) within which the beverage is contained. A closure wall (3) is located over the partition wall (5) and sealed thereto and to the container (1) to form with the partition wall a secondary chamber (11). The primary and secondary chambers (10, 11) communicate with each other through a restricted orifice (9) in the partition wall (5). The assembly is now inverted so that beverage from the primary chamber (10) enters the secondary chamber (11) and a primary headspace (10a) is formed in the primary chamber (10) and a secondary headspace (11a) is formed in the secondary chamber (11). Both said headspaces (10a, 11a) are at a pressure greater than atmospheric so that upon opening the container to expose the primary chamber (10) to atmosphere, beverage and/or gas in the secondary chamber (11) is ejected into the beverage in the primary chamber (10) to develop or assist in the development of a head or froth on the beverage. The pressurisation of the container with the selected gas is preferably to be by dosing with the gas in liquid form before the closure wall is fitted and sealed to the container and either before or after the partition wall has been fitted to the container.
Patent AU-3549684-A (AU)
Title: Controlled expansion alloy
Inventor: SMITH JOHN SCOTT
IPC: C21D6/00
Filed: 1984-11-16
Abstract: Age-hardenable, controlled low expansion nickel-iron and nickel-cobalt-iron alloys containing from 34 to 55% nickel, up to 25% cobalt, 1% to 2% titanium, 1.5% to 5.5% niobium, 0.25% to 1% silicon, up to 1.25% aluminum, up to 0.01% boron, up to 0.12% carbon, the balance, apart from incidental elements and impurities, being iron, are annealed at a temperature from 927 to 1038 DEG C for a period of up to 9 hours, depending on section size; cooled; aged at a temperature from 704 to 816 DEG C for up to 12 hours, depending on section size an aluminum content; cooled; aged at a temperature from 593 to 677 DEG  C for up to 12 hours; and cooled to ambient temperature.
Patent AU-3653797-A (AU)
Title: Side scatter tomography system
Inventor: ROTHSCHILD PETER
IPC: G01N23/04
Filed: 1997-07-08
Abstract: An x-ray tomography system measures x-rays side-scattered by material concealed within an enveloping surface. One or more x-ray beams are incident on the enveloping surface and scattered onto collimated detectors disposed in arrays parallel to the incident x-ray beams. By varying the relative orientation of the enveloping surface with respect to the x-ray beams and measuring the x-rays side-scattered by the material concealed within the enveloping surface, the shape, density, position and composition of the contents of the enveloping surface may be mapped.
Patent AU-3661000-A (AU)
Title: Conveyor for treating hollow bodies comprising an advanced pressure distribution circuit
Inventor: GUIFFANT ALAIN
IPC: F15B13/07
Filed: 2000-03-24
Abstract: Aconveyer for treating hollow bodies, comprising several identical treatment stations (12, 13) that process at least one hollow body, whereby the respective treatment station for a given treatment stage communicates with a pressure source via distribution means that include a tight revolving extention. The invention is characterized in that the machine includes at least two independent and equivalent pressure sources (A1, A2) for the given treatment stage. The invention is also characterized in that it is divided up into the same number of treatment stations (12, 13) as the number of pressure sources existing for the machine and in that the distribution device (18) are such that each pressure source (A1, A2) is associated with a specific group.
Patent AU-3837293-A (AU)
Title: Isolation of fullerenes
Inventor: MULLER WOLFGANG
IPC: C01B31/02
Filed: 1993-05-05
Abstract: The isolation of fullerenes from fullerene-containing soot involves heating of the soot by means of microwaves to from 300 to 800 DEG C and condensing the evaporating fullerenes.
Patent AU-4100093-A (AU)
Title: New pharmaceutical uses of krill enzymes
Inventor: LINDBLOM RAGNVALD
IPC: C12N9/50
Filed: 1993-05-21
Abstract: Non-immunogenic enzyme compositions which have been isolated from antartic krill and exhibit both endo- and exo-peptidase activity, are useful in the manufacture of compositions for the treatment of dental plaque.
Patent AU-4122096-A (AU)
Title: Silver plating
Inventor: SOUTAR ANDREW MCINTOSH
IPC: C23C18/42
Filed: 1995-12-11
Abstract: In PCB manufacture, the pads and/or through-holes of a bare board are protected prior to mounting of other components by a silver plating process. The silver plate is applied from a plating composition by a replacement process in which silver ions oxidized copper and deposit a layer of silver at the surface. In the aqueous plating composition the silver ions are maintained in solution by the incorporation of a multidentate complexing agent. The compositions may contain a silver tarnish inhibitor and are free of reducing agent capable of reducing silver ions to silver metal, halide ions and substantially free of non-aqueous solvent. Surface mounted components can be soldered direct to the silver coated contact using any commercially available solder. Silver does not deposit onto solder mask, but only onto metal which is less electropositive than silver. REEXAMINATION RESULTS The questions raised in reexamination proceedings Nos. 90/012,336 and 90/009,934, filed Jun. 4, 2012 and Aug. 3, 2011 respectively, have been considered, and the results thereof are reflected in this reissue patent which constitutes the reexamination certificate required by 35 U.S.C. 307 as provided in 37 CFR 1.570(e) for ex parte reexaminations, and/or the reexamination certificate required by 35 U.S.C. 316 as provided in 37 CFR 1.997(e) for inter partes reexaminations.
Patent AU-4154993-A (AU)
Title: New peptide compounds active in cell adhesion processes, a process for the preparation thereof, and pharmaceutical compositions containing them
Inventor: FAUCHERE JEAN-LUC
IPC: C07K5/10
Filed: 1993-06-29
Abstract: The invention relates to peptide derivatives of formula (I): R1-A-Gly-Asp-Trp-R2 (I> in which R1, R2 and A are as defined in the description. Medications.
Patent AU-4203293-A (AU)
Title: Arrangement for depositing splicing cassettes for light waveguides within a cable sleeve
Inventor: LATTE FRANK-HELGE
IPC: G02B6/44
Filed: 1993-07-16
Abstract: The invention relates to an arrangement for laying splicing cassettes (1) for optical fibres inside a cable closure. A separate receptacle (2) for excess lengths (4) of individual optical fibres is provided for each splicing cassette (1). The splicing cassette (1) and the receptacle (2) are respectively arranged on a carrier plate (3) and held in a fixing device (9). Each carrier plate (3) can be individually removed from the fixing device (9) without the need in the process to take other carrier plates (3) out of their position. <IMAGE>
Patent AU-4233589-A (AU)
Title: Stable oxapenem-3-carboxylic acids and their use as b-lactamase inhibitors
IPC: C07D503/00
Filed: 1989-09-27
Abstract: The invention relates to the use of 1-oxapenem-3-carboxylic acids of the following structures 
<IMAGE>
 and
 in which R<1> and R<2> have the meaning given in the description, as  beta -lactamase inhibitors and to pharmaceutical compositions which contain the abovementioned 1-oxapenem-3-carboxylic acids and a conventional antibiotic.
Patent AU-4268996-A (AU)
Title: Anchorage assembly
Inventor: GREEN DAVID ROBERT
IPC: E04C5/12
Filed: 1995-12-20
Abstract: The invention relates to anchorage assemblies and in particular to anchorage assemblies having a novel wedge arrangement, wedges for use with anchorage assemblies and an anchorage member. In order to improve wedge performance in an anchorage assembly, a wedge (21) is provided having both internally (24) and externally (25) relieved portions to give a nose area (26) which is tapered to a greater extent than the rest of the wedge (21). Under normal load conditions, the wedge (21) behaves like a short wedge having no nose relief and is highly efficient. However, under high load or load limit conditions, the nose portion (26) of the wedge (21) is arranged to deform plastically so that fretting of the stressing element (23) gripped by the wedge (21) does not occur. As well as the high performance wedge, an improved anchorage member for the anchorage assembly is provided, the anchorage member having a number of steps (34-74). The provision of steps (34-74) in the anchorage member reduces the tendency for anchorage members to be drawn into prestressed concrete structures and reduces the bursting forces within such structures. The combination of an anchorage assembly having the improved wedge and improved anchorage member is a particularly effective and advantageous one.
Patent AU-4343797-A (AU)
Title: Process for converting hydroxy heteroaromatics to arylamines
Inventor: PEET NORTON P
IPC: C07D219/06
Filed: 1997-09-12
Abstract: A process of converting a hydroxy heteroaromatic compound to an arylamine, comprising the steps of : 1) treating a salt of a hydroxy heteroaromatic compound with an alkylating agent; and 2) treating the reaction mixture with a Smiles solvent system and raising the temperature of the reaction mixture; and a compound made according to the above process.
Patent AU-4401096-A (AU)
Title: Baseplate for a pallet container
Inventor: GIEZEN MAURICE GERARDUS MARIA
IPC: B65D77/06
Filed: 1995-12-19
Abstract: PCT No. PCT/NL95/00427 Sec. 371 Date Jul. 10, 1997 Sec. 102(e) Date Jul. 10, 1997 PCT Filed Dec. 19, 1995 PCT Pub. No. WO96/19397 PCT Pub. Date Jun. 27, 1996Baseplate (4) for a pallet container (1). The baseplate (4) is designed to accommodate the container section of a pallet container (1). To ensure run-off of the fluids which are present in the pallet container (1) towards an outflow opening with valve (6) close to a peripheral side of the pallet container (1), the baseplate (4) is constructed with a slope. This slope is such that, in the normal use position of the baseplate (4), this baseplate (4) is constructed with a downward slope to all sides from the center point of this place (4), whilst a peripheral gutter (13) is provided. The lowest point thereof is located at the outflow opening for the fluids.
Patent AU-4451289-A (AU)
Title: Stable low polymerizable monomer emission vinyl ester and unsaturated polyester resin compositions
Inventor: LIEDTKE ROLF FRIEDRICH
IPC: C08L63/10
Filed: 1989-11-09
Abstract: This invention relates to a stable, low level styrene emission vinyl ester or unsaturated polyester resin composition containing a nonionic surfactant or a copolymer of maleic acid half ester of a polyethylene glycol and a monoalkenyl aromatic monomer as stabilizing agents. The resin compositions of the present invention are useful in the manufacture of reinforced plastic components, boat hulls, fireproof molded articles, linings, paints, coating compositions, tanks and the like.
Patent AU-4530893-A (AU)
Title: Preparation of nucleic acid from mononuclear cells
Inventor: RYDER THOMAS B
IPC: C12N5/071
Filed: 1993-06-07
Abstract: Method and kit for the preparation of nucleic acid, such as for amplification. The nucleic acid may be prepared by centrifuging a sample of whole cells, particularly mononuclear cells, with an appropriate centrifugation medium so as to separate desired cells from non-desired cells, then removing and lysing said desired cells. A complexing agent able to complex ferric ion may be added to the lysed cells. The nucleic acid associated with the lysed cells can be amplified, and the nucleic acid can also be screened for a certain nucleic acid sequence, such as a viral nucleic acid sequence.
Patent AU-4611489-A (AU)
Title: A process for the preparation of l-phosphinothricin
Inventor: THEN JOHANN
IPC: C12N9/10
Filed: 1989-12-13
Abstract: L-2-amino-4-methylphosphinobutyric acid can be prepared by racemate resolution in the presence of D-amino-acid transaminase and L-amino- acid transaminase by reaction with  alpha -keto acids and amino-group donors.
Patent AU-4782797-A (AU)
Title: Shock absorber for crutches
Inventor: OLIVERA JORGE REHBERGER
IPC: A61H3/02
Filed: 1997-11-06
Abstract: The device applies to crutches wherein are provided two telescopic tubes (6, 7) which, on the one hand, make possible adjusting the effective height of the crutch and, on the other hand, absorb the impact of the crutch to the ground, the device consisting of a bush (13) which is fitted to the upper extremity of the lower telescopic tube (6) and which has an elongate side hole (15) wherein a pin (11') can play and is secured to the upper external tube (7), precisely through a pair of orifices (12) drilled in said tube so that the length of the elongate orifice (15) of the plug limits the relative motion between the two tubes (6, 7) forming the strut (1), said elements being maintained at a maximum distance from each other by means of a spring (10) positioned between the plug (13) and the second pin (11) of the upper and external tube. <IMAGE>
Patent AU-4925896-A (AU)
Title: Spatial frame
Inventor: TAYLOR HAROLD S
IPC: A61B17/60
Filed: 1996-02-16
Abstract: A spatial frame for positioning a first element or the like relative to a second element or the like. The spatial frame includes a first base for mounting to the first element; a second base for mounting to the second element; a plurality of adjustable effective length struts; connector structure for rotatably attaching the first ends of a first pair of struts relative to one another and relative to the first base; connector structure for rotatably attaching the first ends of a second pair of struts relative to one another and relative to the first base; connector structure for rotatably attaching the first ends of a third pair of struts relative to one another and relative to the first base; connector structure for rotatably attaching the second ends of the first pair of struts relative to one another and relative to the second base; connector structure for rotatably attaching the second ends of the second pair of struts relative to one another and relative to the second base member; and connector structure for rotatably attaching the second ends of the third pair of struts relative to one another and relative to the second base member.
Patent AU-4946199-A (AU)
Title: Bogie construction
Inventor: JURMU RISTO
IPC: B62D13/02
Filed: 1999-06-28
Abstract: A bogie construction includes at least two stiff axles interconnected by a rocking lever. The rocking lever is pivoted in its middle so that it can move in its longitudinal direction as a result of steering movements. The rocking lever is preferably connected to the bogie axle that turns the least, by a joint of an ear, and thus this axle determines the longitudinal displacement of the rocking lever. The rocking lever is connected to the other axles which turn more by suspension rods. A suspension rod pivoted below the axle is used, and thus the suspension rod can be made as long as possible. Consequently, the suspension rod tilts less as a result of the longitudinal movement of the rocking lever.
Patent AU-5006290-A (AU)
Title: Process for destroying hypochlorite in a solution of chlorate
IPC: C25B1/26
Filed: 1990-02-22
Abstract: Destruction of hypochlorites in a chlorate solution, without affecting the hexavalent chromium which is also present, using hydrogen peroxide.
Patent AU-5028499-A (AU)
Title: Apparatus and method for interfering with pathological cells survival processes
Inventor: TOFANI SANTI
IPC: A61N2/04
Filed: 1999-06-23
Abstract: A method and an apparatus for interfering with pathological cells survival, i.e. inducing apoptosis on living pathological cells, by using magnetic fields without adversely affecting normal cells. Static (S) and extremely low frequency (ELF) magnetic fields are used having intensity comprised between 1 and 30 mT. In particular SELF fields are used which are different sequences of S and/or ELF fields, i.e. S fields followed by ELF fields, ELF fields followed by S fields, S and ELF field together, as well as the presence of S or ELF fields alone, said ELF fields having a field frequency comprised between 1 and 1000 Hz. An apparatus for carrying out the method comprises means for generating static magnetic (S) fields crossing a working environment and/or means for generating electromagnetic extremely low frequency (ELF) fields over the working environment in addition to the S fields. Means are provided for modulating the S fields and varying the intensity of the S fields from 1 to 30 mT. Means may also be provided for modulating the ELF fields associated to the ELF fields generating means and imposing to the ELF fields a frequency between 1 and 1000 Hz with intensity comprised between 1 and 30 mT. <IMAGE>